Four-Week Temazepam Taper Schedule from 15 mg
For a patient taking 15 mg temazepam nightly, taper by approximately 25% every 1-2 weeks over four weeks: reduce to 10 mg for weeks 1-2, then to 7.5 mg for weeks 3-4, followed by discontinuation. 1, 2
Specific Weekly Schedule
Week 1-2:
- Reduce dose to 10 mg nightly 1
- This represents a 33% reduction from baseline
- Monitor for withdrawal symptoms (anxiety, insomnia, restlessness) 1
Week 3-4:
- Reduce dose to 7.5 mg nightly 1, 2
- This is the lowest commercially available capsule strength 1
- Continue monitoring for rebound insomnia 1
After Week 4:
- Discontinue temazepam completely 1
- The 7.5 mg dose minimizes risk of rebound insomnia in most patients 3
Rationale for This Approach
Gradual tapering minimizes withdrawal reactions including rebound insomnia, which typically lasts 1-3 days after benzodiazepine discontinuation 1. The FDA label explicitly recommends gradual tapering to reduce withdrawal risk rather than abrupt cessation 2.
The 25% reduction strategy is supported by evidence showing that dose reductions of this magnitude every 1-2 weeks are generally well-tolerated 1, 4. Research demonstrates that temazepam 7.5 mg has low propensity for producing rebound insomnia upon withdrawal 3.
Critical Management Considerations
If withdrawal symptoms become intolerable:
- Pause the taper at the current dose 1, 2
- Consider returning to the previous dose level 2
- Slow the taper further using smaller decrements over longer intervals 1, 5
Tapering frequency can be adjusted:
- Instead of daily dosing at lower doses, consider every-other-night administration to further minimize rebound effects 1
- This approach has been shown to reduce withdrawal symptoms 1
Concurrent behavioral interventions enhance success:
- Cognitive-behavioral therapy for insomnia (CBT-I) increases successful discontinuation rates 1
- Patient agreement and collaborative planning are essential for taper success 5, 6
Common Pitfalls to Avoid
Do not taper too rapidly: Abrupt discontinuation or tapers faster than 25% every 1-2 weeks increase risk of rebound insomnia and withdrawal symptoms 1, 7. Studies show that short tapers of 2-4 weeks down to only therapeutic minimum doses show minimal benefit over abrupt discontinuation 8.
Do not assume all patients tolerate the same rate: While this four-week schedule is appropriate for most patients on 15 mg, those who have used temazepam for longer than one year may require slower tapers 1, 9. For long-term users (>1 year), consider extending the taper to 2-3 months 6.
Monitor closely during withdrawal period: Follow up at least monthly, though more frequent contact (weekly) is preferable during active tapering 5, 6. Rebound insomnia, if it occurs, typically manifests in the first 1-2 nights after dose reduction 7.
Distinguish rebound from recurrence: Rebound insomnia is transient (1-3 days) and represents worsening beyond baseline, while recurrence of underlying insomnia is persistent and returns to pre-treatment levels 1, 7. Research shows temazepam 15-30 mg has relatively low risk of rebound compared to shorter-acting benzodiazepines 7.